OncoBreak: Economic Crisis and Cancer; Red Tape and Meds

Fallout from the 2008 global economic crisis contributed directly or indirectly to an additional 260,000 cancer deaths that otherwise would not have been expected. (The Lancet)

As part of efforts to deal with soaring healthcare costs, China has slashed drug prices by 50% or more, including some anticancer agents. (FiercePharma)

Ahead of its annual meeting, which begins June 3 in Chicago, the American Society of Clinical Oncology (ASCO) has lifted the embargo on most of its 5,817 meeting abstracts, making them available to the public.

Administrative red tape unnecessarily delays many patients' access to oral anticancer medications, according to a study from Fox Chase Center Center to be reported at ASCO.

An oncologist-blogger discusses the importance of regaining sexuality among cancer patients and survivors. (ASCO Connection)

Researchers at the University of Texas MD Anderson Cancer Center have identified genetic mutations that may drive the transformation of colon polyps into cancer. (Cancer Prevention Research)

Just in time for summer, a blogger for Cancer Research Catalyst discusses skin cancer prevention and the latest research on the most common type of cancer worldwide. (AACR)

The investigational inhibitor of cyclin-dependent kinase 4/6 abemaciclib demonstrated activity against a variety of solid tumors -- including breast, lung, brain, and melanoma -- in a phase I clinical trial. (Cancer Discovery)

Testing women for genetic mutations beyond those that have established relationships with breast and ovarian cancer did not provide any clinical benefit. (American Journal of Human Genetics)

Let's block ads! (Why?)

OncoBreak: Economic Crisis and Cancer; Red Tape and Meds